Systemic therapy of kidney cancer: tyrosine kinase...

Future Oncology 2009 / 08 Vol. 5; Iss. 6

Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?

Kirkali, Ziya, Tüzel, Emre
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.09.51
Date:
August, 2009
File:
PDF, 487 KB
english, 2009
Conversion to is in progress
Conversion to is failed